Abi-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Abi-1 monoclonal antibodies for research focused on understanding Abi-1's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Abi-1, or Abl interactor 1, regulates cell signaling pathways, particularly those associated with the Abl tyrosine kinase. Abi-1 plays a significant role in cellular adhesion, migration, and proliferation, making it essential for normal cellular function and development. Research has shown that Abi-1 dysregulation is linked to various diseases, including cancer, highlighting its importance as a target for therapeutic intervention. Studying Abi-1's molecular mechanisms and interactions provides valuable insights into cellular regulation and disease progression. Understanding Abi-1's function in different cellular contexts can lead to new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of Abi-1's role in health and disease.